Results 331 to 340 of about 54,700 (373)
Some of the next articles are maybe not open access.

Drug Eruptions

Primary Care: Clinics in Office Practice, 1978
Although any drug may cause any dermatitis, it is possible to categorize a relatively few types of dermatitis and a relatively small number of drugs in such a way as to afford a practical approach to a sometimes confusing problem. These problems are generally clinical ones not requiring laboratory work and an experienced clinician will probably be able
openaire   +2 more sources

Drug eruptions in the elderly

Clinics in Dermatology, 2011
Because the older group of the population is becoming more numerous, we see a high prevalence in drug adverse reactions among the elderly. Polypharmacy, which is the use of five or more medications, is one reason why this group has a greater risk of adverse drug reactions.
Marcia Ramos-e-Silva   +2 more
openaire   +3 more sources

Neutrophilic drug eruptions

Clinics in Dermatology, 2000
It is often stated that drug reactions may induce or mimic all skin disorders. This applies also to several “classic” neutrophilic dermatoses and especially to Sweet’s syndrome. In addition, some uncommon types of drug eruptions qualify as neutrophilic dermatoses: bromoderma, iododerma, and the less rare acute generalized exanthematous pustulosis (AGEP)
openaire   +3 more sources

The dermatopathology of drug eruptions

Current Problems in Dermatology, 2002
Abstract Cutaneous drug eruptions are among the most common adverse reactions to drug therapy, the etiology of which reflects immunologic and/or nonimmunologic mechanisms, the former encompassing all of the classic immune mechanisms of Gell and Combs.
Cynthia M. Magro, A. Neil Crowson
openaire   +2 more sources

It is not a fixed drug eruption, it is a fixed “sunlight” eruption

International Journal of Dermatology, 2010
AbstractHyperpigmented fixed eruption is a phenomenon usually related with drug antigens, and known as fixed drug eruption. A woman had a skin condition with clinical and histopathologic indications of fixed drug eruption. The disease first appeared when she went to a swimming pool and left with hyperpigmented macules.
Rommel Valdivieso, Cecilia Cañarte
openaire   +3 more sources

Cutaneous Drug Eruptions

Veterinary Clinics of North America: Small Animal Practice, 1990
A drug-induced cause should be considered by the veterinarian when presented with any dermatosis and, in particular, those dermatoses that seem to have an underlying immunologic mechanism. A detailed history should be taken and a thorough dermatologic examination always performed.
openaire   +3 more sources

Drug eruptions in the mature patient

Clinics in Dermatology, 2018
The world's population is now ageing at an unprecedented rate. Declining fertility and improved health and longevity have generated rising numbers and proportions of the older population in most parts of the world. With advancing age, however, comes an increasing incidence of disease (comorbidity or multimorbidity), an increasing use of medications ...
Branka Marinović, Ronni Wolf
openaire   +4 more sources

FIXED DRUG ERUPTION*

Australasian Journal of Dermatology, 1983
SummaryThe enigma of fixed drug eruption has fascinated dermatologists for over eighty years. The clinical features and investigative studies suggest that many immunopathogenic mechanisms may be involved. Fixed drug eruption offers a unique opportunity to study the early events of inflammation and the factors controlling localizations of skin disease.
openaire   +3 more sources

Bullous drug eruption

Clinical and Experimental Dermatology
Reactions to intravenous contrast media can be immediate or delayed, with delayed hypersensitivity reactions occurring 1 h to 7 days after administration. Severe reactions such as generalized bullous fixed drug eruption are rare. Skin tests, including patch and intradermal tests, are used to identify culprit agents.
Dora, Mancha   +6 more
openaire   +2 more sources

HLA and Allopurinol Drug Eruption

Dermatology, 1989
Strong HLA associations were found in Southern Chinese patients with skin eruptions due to allopurinol. The positive associations were with AW33 (Pc = 1.7 × 10<sup>-5</sup>; relative risk [RR] = 15.0, 95% confidence limit 5.2–42.9) with B17/BW58 (Pc = 2.9 × 10<sup>-9</sup>; RR = 46.3, 95% confidence limit 10.3–209.2).
Chan, S.H., Tan, T.
openaire   +3 more sources

Home - About - Disclaimer - Privacy